Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Markowitz

Showing results (121-130 of 247) with videos related to

Pageof 25
Sort By:
Cancer Research|November 14, 1997
O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNUW P Phillips, J K Willson, S D Markowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polypsZsolt Petko, Mahan Ghiassi, Anthony Shuber, et al.
American Journal of Ophthalmology|November 1, 1996
Long-term follow-up of ocular findings in children with Stickler's syndromeM C Wilson, D M McDonald-McGinn, G E Quinn, et al.
Journal of the National Cancer Institute|April 20, 2001
Testing for colon neoplasia susceptibility variants at the human COX2 locusG L Wiesner, P Platzer, S Buxbaum, et al.
Cancer Research|July 15, 1992
Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27M Schrappe, T F Bumol, L D Apelgren, et al.
Plos Genetics|July 23, 2013
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancerYanxin Luo, Andrew M Kaz, Samornmas Kanngurn, et al.
Journal of the National Cancer Institute|March 16, 2000
Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cellsW D Chen, J R Eshleman, M R Aminoshariae, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologiesHelen Moinova, Rom S Leidner, Lakshmeswari Ravi, et al.
Scientific Reports|March 24, 2016
Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancerSrividya Venkitachalam, Leslie Revoredo, Vinay Varadan, et al.
Epigenetics|July 18, 2015
MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated allelesMing Yu, Kelly T Carter, Karen W Makar, et al.
Pageof 25

Showing results (121-130 of 247) with videos related to

Sort By:
Pageof 25
Cancer Research|November 14, 1997
O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNUW P Phillips, J K Willson, S D Markowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polypsZsolt Petko, Mahan Ghiassi, Anthony Shuber, et al.
American Journal of Ophthalmology|November 1, 1996
Long-term follow-up of ocular findings in children with Stickler's syndromeM C Wilson, D M McDonald-McGinn, G E Quinn, et al.
Journal of the National Cancer Institute|April 20, 2001
Testing for colon neoplasia susceptibility variants at the human COX2 locusG L Wiesner, P Platzer, S Buxbaum, et al.
Cancer Research|July 15, 1992
Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27M Schrappe, T F Bumol, L D Apelgren, et al.
Plos Genetics|July 23, 2013
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancerYanxin Luo, Andrew M Kaz, Samornmas Kanngurn, et al.
Journal of the National Cancer Institute|March 16, 2000
Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cellsW D Chen, J R Eshleman, M R Aminoshariae, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2012
Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologiesHelen Moinova, Rom S Leidner, Lakshmeswari Ravi, et al.
Scientific Reports|March 24, 2016
Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancerSrividya Venkitachalam, Leslie Revoredo, Vinay Varadan, et al.
Epigenetics|July 18, 2015
MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated allelesMing Yu, Kelly T Carter, Karen W Makar, et al.
Pageof 25